Lillemor Melander Skattum

Medicine & Life Sciences

1. Complement C3 Nephritic Factor 100%
2. Hereditary Complement Deficiency Diseases 91%
3. Conjugate Vaccines 73%
4. Vaccination 65%
5. Pneumococcal Vaccines 64%
6. Autoantibodies 62%
7. Vasculitis 48%
8. Serogroup 44%
9. Serum 43%
10. Antirheumatic Agents 40%
11. Immunoglobulin G 40%
12. Antibody Formation 40%
13. Systemic Lupus Erythematosus 39%
14. 13-valent pneumococcal vaccine 35%
15. Mannose-Binding Lectin 34%
16. Antibodies 33%
17. Hereditary Angioedemas 31%
18. Complement System Proteins 31%
19. Properdin 29%
20. Complement Factor H 29%
21. Antineutrophil Cytoplasmic Antibodies 28%
22. Complement Activation 28%
23. Rheumatoid Arthritis 27%
24. Alternative Complement Pathway 27%
25. Infections 26%
26. Rituximab 25%
27. Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 25%
28. Methotrexate 23%
29. Complement Factor I Deficiency 23%
30. Enzyme-Linked Immunosorbent Assay 21%
31. Neisseria meningitidis 21%
32. Immunoglobulins 21%
33. Acquired angioedema 19%
34. Glomerulonephritis 19%
35. B-Lymphocytes 19%
36. belimumab 18%
37. Membranoproliferative Glomerulonephritis 17%
38. Child 17%
39. Neonatal Screening 17%
40. eculizumab 16%
41. Immunoglobulin M 16%
42. Abatacept 15%
43. Mutation 15%
44. Immunization 15%
45. Standard of Care 15%
46. Therapeutics 14%
47. Meningococcal Infections 14%
48. Immunoassay 14%
49. Haemophilus influenzae type b 14%
50. Systemic Vasculitis 14%